172 related articles for article (PubMed ID: 35041512)
21. Clinical significance of breakthrough fungemia caused by azole-resistant Candida tropicalis in patients with hematologic malignancies.
Myoken Y; Kyo T; Fujihara M; Sugata T; Mikami Y
Haematologica; 2004 Mar; 89(3):378-80. PubMed ID: 15020289
[TBL] [Abstract][Full Text] [Related]
22. [Three cases of fungemia caused by Blastoschizomyces capitatus].
Koç AN; Copur Çiçek A; Kaynar L; Sav H; Kasap Tekinşen FF; Atalay MA
Mikrobiyol Bul; 2013 Oct; 47(4):734-41. PubMed ID: 24237444
[TBL] [Abstract][Full Text] [Related]
23. Fungemia due to rare non-Candida yeasts between 2018 and 2021 in a Greek tertiary care university hospital.
Spiliopoulou A; Lekkou A; Vrioni G; Leonidou L; Cogliati M; Christofidou M; Marangos M; Kolonitsiou F; Paliogianni F
J Mycol Med; 2023 Aug; 33(3):101386. PubMed ID: 37031651
[TBL] [Abstract][Full Text] [Related]
24. Candida norvegensis fungemia in a liver transplant recipient.
Sanclemente G; Marco F; Cervera C; Hoyo I; Colmenero J; Pitart C; Almela M; Navasa M; Moreno A
Rev Iberoam Micol; 2015; 32(2):115-7. PubMed ID: 24794213
[TBL] [Abstract][Full Text] [Related]
25. [Fungemia due to Trichosporon asahii in a patient with hematological malignancy].
Odero V; Galán-Sánchez F; García-Agudo L; García-Tapia AM; Guerrero-Lozano I; Rodríguez-Iglesias MA
Rev Iberoam Micol; 2015; 32(1):59-61. PubMed ID: 24071639
[TBL] [Abstract][Full Text] [Related]
26. Molecular and antifungal susceptibility study on trichosporonemia and emergence of Trichosporon mycotoxinivorans as a bloodstream pathogen.
Dabas Y; Xess I; Kale P
Med Mycol; 2017 Jul; 55(5):518-527. PubMed ID: 27816903
[TBL] [Abstract][Full Text] [Related]
27. Trichosporon asahii fungemia in a patient with non-hematological malignancy.
Karabay O; Madariaga MG; Kocoglu E; Ince N; Kandirali E
Jpn J Infect Dis; 2006 Apr; 59(2):129-31. PubMed ID: 16632916
[TBL] [Abstract][Full Text] [Related]
28. Persistent fungemia--risk factors and outcome in 40 episodes.
Kovacicova G; Lovaszova M; Hanzen J; Roidova A; Mateicka F; Lesay M; Krcméry V
J Chemother; 2001 Aug; 13(4):429-33. PubMed ID: 11589487
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment of breakthrough disseminated
Karigane D; Sakurai M; Matsuyama E; Ide K; Yamamoto-Takeuchi S; Inazumi T; Kohashi S
Med Mycol Case Rep; 2018 Jun; 20():1-3. PubMed ID: 29264110
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
[TBL] [Abstract][Full Text] [Related]
31. Fungemia due to Fusarium solani under low-dose liposomal amphotericin B in a patient after cord blood transplantation.
Konuma T; Takahashi S; Kiyuna T; Misawa Y; Suzuki M; Isobe M; Jimbo K; Mizusawa M; Kato S; Takahashi S; Tojo A
J Infect Chemother; 2019 Aug; 25(8):635-638. PubMed ID: 30910505
[TBL] [Abstract][Full Text] [Related]
32. [Multicenter study of fungemia due to yeasts in Argentina].
Rodero L; Davel G; Soria M; Vivot W; Córdoba S; Canteros CE; Saporiti A;
Rev Argent Microbiol; 2005; 37(4):189-95. PubMed ID: 16502638
[TBL] [Abstract][Full Text] [Related]
33. Evolution of fungemia in an Italian region.
Prigitano A; Cavanna C; Passera M; Gelmi M; Sala E; Ossi C; Grancini A; Calabrò M; Bramati S; Tejada M; Lallitto F; Farina C; Rognoni V; Fasano MA; Pini B; Romanò L; Cogliati M; Esposto MC; Tortorano AM
J Mycol Med; 2020 Apr; 30(1):100906. PubMed ID: 31708424
[TBL] [Abstract][Full Text] [Related]
34. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance.
Nguyen MH; Peacock JE; Morris AJ; Tanner DC; Nguyen ML; Snydman DR; Wagener MM; Rinaldi MG; Yu VL
Am J Med; 1996 Jun; 100(6):617-23. PubMed ID: 8678081
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology and Outcome of Trichosporon Fungemia: A Review of 185 Reported Cases From 1975 to 2014.
Liao Y; Lu X; Yang S; Luo Y; Chen Q; Yang R
Open Forum Infect Dis; 2015 Dec; 2(4):ofv141. PubMed ID: 26566536
[TBL] [Abstract][Full Text] [Related]
36. Candida lusitaniae: a cause of breakthrough fungemia in cancer patients.
Minari A; Hachem R; Raad I
Clin Infect Dis; 2001 Jan; 32(2):186-90. PubMed ID: 11170906
[TBL] [Abstract][Full Text] [Related]
37. Rare yeasts causing fungemia in immunocompromised and haematology patients: Case series from Delhi.
Capoor MR; Gupta DK; Verma PK; Sachdeva HC
Indian J Med Microbiol; 2015; 33(4):576-9. PubMed ID: 26470968
[TBL] [Abstract][Full Text] [Related]
38. Successful Outcome of Disseminated Fusarium musae Fungemia with Skin Localization Treated with Liposomal Amphotericin B and Voriconazole in a Patient with Acute Myeloid Leukemia.
Verbeke V; Bourgeois T; Lodewyck T; Van Praet J; Lagrou K; Reynders M; Nulens E
Mycopathologia; 2020 Dec; 185(6):1085-1089. PubMed ID: 33119817
[TBL] [Abstract][Full Text] [Related]
39. Amphotericin B treatment of fungemia due to unusual pathogens in neutropenic patients: report of two cases.
Fanci R; Pecile P; Martinez RL; Fabbri A; Nicoletti P
J Chemother; 1997 Dec; 9(6):427-30. PubMed ID: 9491843
[TBL] [Abstract][Full Text] [Related]
40.
Santos FA; Leite-Andrade MC; Vasconcelos MA; Alves AI; Buonafina-Paz MD; Araújo-Neto LN; Macêdo DP; Neves RP
Future Microbiol; 2022 Jan; 17():81-87. PubMed ID: 34913372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
